Get the latest news alerts: at Twitter.

Local Tech Wire

RESEARCH TRIANGLE PARK, N.C. – Medical device startup is now operating with a new vice president for global marketing.

Luke Roush joins the venture-backed firm that is selling a new device for use in laparoscopic surgery called the SPIDER Surgical System. Roush was formerly chief operating officer at

Todd Pope, the chief executive officer at venture-backed TransEnterix, is a former Liquidia CEO.

“TransEnterix’s vision of transforming the surgical experience for patients and surgeons alike is an ambitious one,”Pope said in a statement. “Luke possesses the strategic thinking and tactical know-how to help bring that vision to fruition as we address surgeon and patient needs in a worldwide, multi-billion dollar marketplace.”

At Liquidia, Roush helped lead efforts in research around the use of nanotechnology.

TransEnterix raised $55 million in venture funding last fall to begin commercialization of SPIDER. Investors included Intersouth Partners of Durham and Quaker BioVentures. Existing backers SV Life Science Advisers, Synergy Life Science Partners and Parish Capital Advisors also participated in the round. In all, the firm has raised $75 million.

Laparoscopic surgery, which involves operations through a small incision and surgeons are assisted by a video camera. The device has been approved by the Food and Drug Administration and was designed with the help of physicians.

SPIDER is an acronym for Single Port Instrument Delivery Extended Reach. In September, the Society of Laparoendoscopic Surgeons picked the Spider as its innovation of the year.

Unlike other devices, Spider enables surgeons to operate with one small incision.

Roush is holder of two potential patents for the use of medical devices in delivering nanoparticle therapeutics and a third patent pending for stent technology. He attended Duke University, earning an MBA in business and bachelor’s of arts degree.